Luca Pani

Dr. Pani is a Professor of Psychiatry – Clinical Track in the Department of Psychiatry and Behavioral Sciences at the University, with expertise in Pharmacology and Molecular Biology. He is a Fellow of the National Research Council of Italy, and served as Director General of the Italian Medicines Agency (AIFA), with CEO roles of both Regulator and Negotiator/Payer.

Dr. Pani served as the Italian Alternate Member of the Committee for Human Medicine Products (CHMP), Full Member of the Scientific Advice Working Party (SAWP), and participant of the Working Party on Central Nervous System (WPCNS). He also has been the Chair of both the European Union Management Board Telematic Committee (EUMBTC) and the EU Network Pharmacovigilance Oversight Group for the European Medicines Agency (EMA) in London (UK). Since 2017, he has served as Chief Scientific Officer of EDRA-LSWR Publishing Company in Milan, Italy and Inpeco SA Total Lab Automation Company in Lugano, Switzerland and the Executive Director for Global Medical Innovation at NeuroCog in Durham, North Carolina.

Dr. Pani is the author of over 160 scientific publications, editor and author of several volumes including Sustainable Innovation: Medicines and the Challenges for the Future of our National Health Service.